|
I hope this email finds you well as we wrap up the month of April. We're looking forward to continuing to share meaningful updates, resources, and opportunities to stay engaged in the work ahead.
In recognition of Fabry Awareness Month, we are bringing attention to a rare condition that often goes unrecognized while supporting those navigating its challenges every day. We invite you to learn more, explore available support, and hear from Wes and Lori as they share their healthcare journeys.
We're also pleased to share with you our latest insights on the evolving realities of care. Accessia Health's two newest blogs explore financial toxicity and how individuals and families can better plan for the long-term costs associated with rare and chronic conditions, along with a thoughtful perspective by VP of Clinical Strategy, Jennifer Noonan, on the future of rare disease and the growing impact of cell and gene therapy.
This week, our team is at the Asembia AXS26 Summit from April 26 through April 30. If you are a partner, advocate, or industry leader attending, we'd love to connect with you for conversation and resources for patient access and affordability. Please feel free to reach out to me, Jennifer Noonan, or EVP of Development & Growth, Alan Wood to schedule a time to visit; or come find us at Booth #1416.
It's always a pleasure to have you alongside us as we continue working to expand access, share knowledge, and support individuals and families navigating care.
Thank you for being a part of our community. Your involvement and trust in us drives the impact behind everything we do.
|